Lilibeth L Torno, MD
Office and Contact Information
CHOC Children's Specialists
1201 W La Veta
Orange, CA 92868
phone: (714) 509-8636
fax: (714) 509-4748
map & directions
- Oncology, CHOC Children's Specialists
- Clinical Director, CHOC After the Cancer Treatment Survivorship (ACTS) Program, CHOC Cancer Institute
Physician / Researcher BioDr. Lilibeth Torno is the Clinical Director, Outpatient Services and the CHOC ACTS (After the Cancer Treatment Survivorship Program. She also leads the Ambulatory Care Services of The CHOC Cancer Institute and directs the CHOC Long Term Follow-up Clinic for survivors of childhood cancer. The outpatient clinic provides comprehensive care of children undergoing chemotherapy, as well as those who have completed therapy. She is board certified in pediatrics and pediatric hematology/oncology. Dr. Torno completed her fellowship training at Children's Hospital of Los Angeles. She completed her residency at CHOC. She attended medical school at University of Santo Tomas, Manila, Philippines.
- Medical School
University of Santo Tomas, Manila, Philippines
- Pediatrics Residency
Children's Hospital of Orange County, Orange, CA
- Pediatric Hematology and Oncology Fellowship
Children's Hospital of Los Angeles, CA
- Pediatric Hematology/Oncology
Honors and Awards
- Physician of Excellence
OCMA, Multiple years
- American Academy of Pediatrics
- American Association for Cancer Research
- Histiocyte Society
ResearchDr. Torno is currently involved in a number of research projects in association with the Children’s Oncology Group (COG). She is currently clinical investigator in several COG bone and soft tissue cancer treatment studies.
Independent of her work with COG, Dr. Torno is very involved in researching cancer survivorship and educating cancer survivors on the long-term impact of their cancers and treatments. To further this interest, Dr. Torno is involved in the Childhood Cancer Survivorship Study. In this multi-center study, Dr. Torno and others are looking at long-term health and quality of life in childhood cancer survivors. Dr. Torno is also in the process of developing an educational curriculum for survivors ages 15 and older. In the future, she hopes to create curriculum for younger children.
Dr. Torno has spoken at numerous conferences and symposiums regionally and internationally on long-term cancer survivorship, histiocytosis treatment, and more.
Lectures and Presentations
- “Liver Lesions in Childhood Cancer Survivors: Review of Case Reports and Institutional Observation"
- "Navigating the Healthcare System for the Childhood Cancer Survivor."
- "Mediastinal Mass and Its Treatment: A single Institution Experience."
- "Time Points in weight changes among survivors of childhood cancer."
- "Tracking Psychosocial needs post treatment in the Cancer Institute"
Histiocytosis - Dr. Lilibeth Torno
Dr. Lilibeth Torno, Clinical Director of Hyundai Cancer Institute at CHOC Children's, describes symptoms and treatment of histiocytosis. Plus, Megan El-Hinn describes her role as Oncology Case Coordin ...
CHOC Articles & Publications
|Miraculous Recovery Gives Little Girl Second Chance at Life
Making a Mark: October 2007
They?ll never forget the date?May 22, 2006. That was the day Patrick and Bridget Colby watched as their 2-yearold daughter Sophia bravely fought for her life. As Sophia lay in the Pediatric Inten...
|More than 80 CHOC Children's Doctors Named "Physicians of Excellence"
January 03, 2012
More than 80 CHOC Children's physicians, including specialists and pediatricians, are named "Physicians of Excellence" by the Orange County Medical Association....
|More than 60 CHOC Children’s Doctors Named “Physicians of Excellence”
January 04, 2011
More than 60 CHOC Children’s physicians, including specialists and pediatricians, are featured as "Physicians of Excellence" in the January 2011 issue of Orange Coast magazine. The "Physicians of Exc...
Hassan M, Lin C, Torno L. (2013) Risk Factors for Obesity and Time Frame of Weight Gain in Non-Irradiated Survivors of Pediatric Acute Lymphoblastic Leukemia. Journal of Cancer Therapy 4: 124-132
doi:10.4236/jct.2013.41017. Published online February 2013